Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Send a message to the White House demanding bold action to stop COVID-19 and end the pandemic! Take Action
Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and Covid at 12th WTO Ministerial
Polling Memo: Public Anger About Corporate Power Dominant Factor in Views on Trade and TPP. July 13, 2016
U.S. Pharmaceutical Corporation Uses NAFTA Foreign Investor Privileges Regime to Attack Canada’s Patent Policy, Demand $100 Million for Invalidation of a Patent March 1, 2017